David I. Kuperman, M.D.

Publications

• Kuperman DI, Dipersio JF
  Bone marrow transplant in the management of solid tumors.
  In: Surgical Oncology: multidisciplinary approach to difficult problems (2nd edition), in press
• Kuperman DI
  Head and neck cancer.
  In: Devita, Hellman, and Rosenberg's: Principles and Practice of Oncology Review. Lippincott. (2nd edition), in press
• Dandona MA, Morgensztern D, Auethavekiat V, Adkins D, Thorstad W, Nussenbaum B, Zhang Q, Kuperman DI
  Survival for nasopharyngeal cancer with distant metastatic disease at presentation.
  Proceedings of the American Society of Clinical Oncology, 2009
• Mosely JC, Ganz B, Rachocki T, Ley J, Seckfort D, Morgensztern D, Kuperman DI, Adkins DR
  Efficacy of cetuximab-based second-line therapy in patients with metastatic head and neck squamous cell carcinoma (HNSCC) which progressed on gefitinib-based first-line therapy.
  Proceedings of the American Society of Clinical Oncology, 2008
• Waqar SN, Tan BR, Zubal B, Kuperman DI, Adkins DR
  Race and albuterol premedication are risk factors for hypersensitivity reactions to cetuximab.
  Proceedings of the American Society of Clinical Oncology, 2008
• Kuperman DI, Adkins DR, Auethavekiat V, Nussenbaum B, Trinkaus K, Morgensztern D
  quamous cell cancer of the head and neck (SCCHN) with distant metastasis at presentation.
  Proceedings of the American Society of Clinical Oncology, 2008
• Chia Y, Kuperman DI
  Head and neck cancer.
  In: The Washington Manual Hematology and Oncology Subspecialty Consult. Lippincott. (2nd edition), 2008
• Waqar S, Kuperman DI
  Sarcoma.
  In: The Washington Manual Hematology and Oncology Subspecialty Consult. Lippincott. (2nd edition), 2008
• Kuperman DI
  Other GI malignancies.
  In: The Washington Manual Hematology and Oncology Subspecialty Consult. Lippincott. (2nd edition), 2008
• Kuperman DI, Nussenbaum B, Thorstad W, Haughey B, Lewis J, Adkins D
  Retrospective analysis of the addition of cetuximab to induction chemotherapy (IC) with cisplatin, docetaxel, and 5-fluorouracil (TPF-C) for locally advanced non-metastatic squamous cell carcinoma of the head and neck (HNSCC).
  Proceedings of the American Society of Clinical Oncology, 2007
• Kuperman DI, Adkins D
  Sarcoma.
  In: The Washington Manual of Oncology, Lippincott (2nd edition), 2007
• Kuperman DI, Adkins D
  Head and neck cancer.
  In: The Washington Manual of Oncology, Lippincott (2nd edition), 2007
• Kuperman DI, Baggstrom M
  Esophageal and gastric cancer.
  In: The Washington Manual of Oncology, Lippincott (2nd edition), 2007
• Van Tine B, Augustin K, Kuperman DI, Nervi B, Westervelt P, DiPersio J
  Salvage therapy with Flag/Idarubicin/Mylotarg (Flag-IM) results in a superior CR/CRp rate and low toxicity when compared to Mitoxantrone/Etoposide/Cytarabine (MEC) in patients with relapsed and refractory AML.
  Proceedings of the American Society of Hematology, 2006
• Wang D, Averett L, Kuperman DI, Gerstenblith G
  ECG analysis.
  In: The Osler Handbook of Medicine, Mosby (2nd edition), 2006
• Kuperman DI, Rahman JE, Donovan K
  ECG analysis.
  In: The Osler Handbook of Medicine, Mosby (1st edition), 2004
• Kuperman DI, Freyaldenhoven TE, Schmued LC, Ali SF
  Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction.
  Brain Res 1997 Oct 17;771(2):221-7